The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Near‐Infrared Upconversion Mesoporous Cerium Oxide Hollow Biophotocatalyst for Concurrent pH‐/H2O2‐Responsive O2‐Evolving Synergetic Cancer Therapy
Abstract
Tumor hypoxia is typically presented in the central region of solid tumors, which is mainly caused by an inadequate blood flow and oxygen supply. In the conventional treatment of hypoxic human tumors, not only the oxygen‐dependent photodynamic therapy (PDT), but also antitumor drug‐based chemotherapy, is considerably limited. The use of direct oxygen delivering approach with oxygen‐dependent PDT or chemotherapy may potentiate the reactive oxygen species (ROS)‐mediated cytotoxicity of the drug toward normal tissues. Herein, a synergetic one‐for‐all mesoporous cerium oxide upconversion biophotocatalyst is developed to achieve intratumorally endogenous H 2 O 2‐responsive self‐sufficiency of O 2 and near‐infrared light controlled PDT simultaneously for overcoming hypoxia cancer. Furthermore, the sufficient O 2 plays an important role in overcoming the chemotherapeutic drug‐resistant cancer caused by hypoxia, therefore inducing tumor cell apoptosis significantly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
TURCHI, C. (1990) · Journal of Catalysis · doi:10.1016/0021-9517(90)90269-p · Cited by 2,093
Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles
Korsvik, C., Patil, S., Seal, S., & Self, W. T. (2007) · Chemical Communications · doi:10.1039/b615134e · Cited by 1,278
Nanoceria exhibit redox state-dependent catalase mimetic activity
Pirmohamed, T., Dowding, J. M., Singh, S., Wasserman, B., Heckert, E., Karakoti, A. S., King, J. E. S., Seal, S., & Self, W. T. (2010) · Chemical Communications · doi:10.1039/b922024k · Cited by 1,214
Pharmacological potential of cerium oxide nanoparticles
Celardo, I., Pedersen, J. Z., Traversa, E., & Ghibelli, L. (2011) · Nanoscale · doi:10.1039/c0nr00875c · Cited by 1,151
Xu, C., & Qu, X. (2014) · NPG Asia Materials · doi:10.1038/am.2013.88 · Cited by 1,133
Chen, Q., Feng, L., Liu, J., Zhu, W., Dong, Z., Wu, Y., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201601902 · Cited by 1,034
Zhu, Y., Shi, J., Shen, W., Dong, X., Feng, J., Ruan, M., & Li, Y. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501500 · Cited by 1,011
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Rare-Earth Doping in Nanostructured Inorganic Materials
Zheng, B., Fan, J., Chen, B., Qin, X., Wang, J., Wang, F., Deng, R., & Liu, X. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00644 · Cited by 1,204
Innovative Strategies for Hypoxic‐Tumor Photodynamic Therapy
Li, X., Kwon, N., Guo, T., Liu, Z., & Yoon, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805138 · Cited by 1,175
Self-citationNanocatalytic Tumor Therapy by Biomimetic Dual Inorganic Nanozyme‐Catalyzed Cascade Reaction
Gao, S., Lin, H., Zhang, H., Yao, H., Chen, Y., & Shi, J. (2019) · Advanced Science · doi:10.1002/advs.201801733 · Cited by 645
Kim, J., Kim, H. Y., Song, S. Y., Go, S.-H., Sohn, H. S., Baik, S., Soh, M., Kim, K., Kim, D., Kim, H.-C., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b08785 · Cited by 550
Metal Oxide Nanoparticles as Biomedical Materials
Nikolova, M. P., & Chavali, M. S. (2020) · Biomimetics · doi:10.3390/biomimetics5020027 · Cited by 510
Versatile Types of Organic/Inorganic Nanohybrids: From Strategic Design to Biomedical Applications
Zhao, N., Yan, L., Zhao, X., Chen, X., Li, A., Zheng, D., Zhou, X., Dai, X., & Xu, F.-J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00401 · Cited by 429
Feng, L., Xie, R., Wang, C., Gai, S., He, F., Yang, D., Yang, P., & Lin, J. (2018) · ACS Nano · doi:10.1021/acsnano.8b05042 · Cited by 422
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease Treatment
Zhang, C., Wang, X., Du, J., Gu, Z., & Zhao, Y. (2021) · Advanced Science · doi:10.1002/advs.202002797 · Cited by 401
Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics
Zhao, S., Yu, X., Qian, Y., Chen, W., & Shen, J. (2020) · Theranostics · doi:10.7150/thno.42564 · Cited by 390
Photodynamic therapy for hypoxic tumors: Advances and perspectives
Huang, L., Zhao, S., Wu, J., Yu, L., Singh, N., Yang, K., Lan, M., Wang, P., & Kim, J. S. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.213888 · Cited by 366
Self-citationCai, L., Chen, J., Liu, Z., Wang, H., Yang, H., & Ding, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00790 · Cited by 365
Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics
Gong, F., Yang, N., Wang, X., Zhao, Q., Chen, Q., Liu, Z., & Cheng, L. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100851 · Cited by 359
Dong, S., Dong, Y., Liu, B., Liu, J., Liu, S., Zhao, Z., Li, W., Tian, B., Zhao, R., He, F., et al. (2022) · Advanced Materials · doi:10.1002/adma.202107054 · Cited by 349
2D Piezoelectric Bi2MoO6 Nanoribbons for GSH‐Enhanced Sonodynamic Therapy
Dong, Y., Dong, S., Liu, B., Yu, C., Liu, J., Yang, D., Yang, P., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202106838 · Cited by 337
Liang, S., Deng, X., Xu, G., Xiao, X., Wang, M., Guo, X., Ma, P., Cheng, Z., Zhang, D., & Lin, J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908598 · Cited by 324
Wang, J., Tang, W., Yang, M., Yin, Y., Li, H., Hu, F., Tang, L., Ma, X., Zhang, Y., & Wang, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120784 · Cited by 317
Xu, J., Han, W., Yang, P., Jia, T., Dong, S., Bi, H., Gulzar, A., Yang, D., Gai, S., He, F., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201803804 · Cited by 315
Aggressive Man‐Made Red Blood Cells for Hypoxia‐Resistant Photodynamic Therapy
Liu, W., Liu, T., Zou, M., Yu, W., Li, C., He, Z., Zhang, M., Liu, M., Li, Z., Feng, J., et al. (2018) · Advanced Materials · doi:10.1002/adma.201802006 · Cited by 310
Recent Advances in Glucose‐Oxidase‐Based Nanocomposites for Tumor Therapy
Wang, M., Wang, D., Chen, Q., Li, C., Li, Z., & Lin, J. (2019) · Small · doi:10.1002/smll.201903895 · Cited by 302
Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy
Zhang, J., Lin, Y., Lin, Z., Wei, Q., Qian, J., Ruan, R., Jiang, X., Hou, L., Song, J., Ding, J., et al. (2022) · Advanced Science · doi:10.1002/advs.202103444 · Cited by 292
Xu, J., Shi, R., Chen, G., Dong, S., Yang, P., Zhang, Z., Niu, N., Gai, S., He, F., Fu, Y., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c00082 · Cited by 274
Dong, S., Dong, Y., Zhao, Z., Liu, J., Liu, S., Feng, L., He, F., Gai, S., Xie, Y., & Yang, P. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c09608 · Cited by 267
Sun, Q., Bi, H., Wang, Z., Li, C., Wang, X., Xu, J., Zhu, H., Zhao, R., He, F., Gai, S., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119473 · Cited by 264
The concept and examples of type-III photosensitizers for cancer photodynamic therapy
Yao, Q., Fan, J., Long, S., Zhao, X., Li, H., Du, J., Shao, K., & Peng, X. (2022) · Chem · doi:10.1016/j.chempr.2021.10.006 · Cited by 256
Sun, Y., Zhao, D., Wang, G., Wang, Y., Cao, L., Sun, J., Jiang, Q., & He, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.004 · Cited by 250
Metadata
- Authors
- Yao, C., Wang, W., Wang, P., Zhao, M., Li, X., & Zhang, F.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2018-01-08
- Volume
- 30
- Issue
- 7
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2782879922
- Cited by
- 447
- References
- 47
- FWCI
- 23.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.